André B. Mulder

3.0k total citations
70 papers, 1.9k citations indexed

About

André B. Mulder is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, André B. Mulder has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 16 papers in Molecular Biology and 16 papers in Genetics. Recurrent topics in André B. Mulder's work include Acute Myeloid Leukemia Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hematopoietic Stem Cell Transplantation (8 papers). André B. Mulder is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Hematopoietic Stem Cell Transplantation (8 papers). André B. Mulder collaborates with scholars based in Netherlands, United Kingdom and Belgium. André B. Mulder's co-authors include Edo Vellenga, Hanneke C. Kluin‐Nelemans, Nic J.G.M. Veeger, I. Vermes, Jan Jacob Schuringa, René Mulder, Karina Meijer, Esther de Vries, Eugenie Gemen and Wim C.J. Hop and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Cell.

In The Last Decade

André B. Mulder

67 papers receiving 1.8k citations

Peers

Countries citing papers authored by André B. Mulder

Since Specialization

Citations

This map shows the geographic impact of André B. Mulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André B. Mulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André B. Mulder more than expected).

Fields of papers citing papers by André B. Mulder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André B. Mulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André B. Mulder. The network helps show where André B. Mulder may publish in the future.

Co-authorship network of co-authors of André B. Mulder

This figure shows the co-authorship network connecting the top 25 collaborators of André B. Mulder. A scholar is included among the top collaborators of André B. Mulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André B. Mulder. André B. Mulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression 2024 ·Transplantation and Cellular Therapy ·Linde M. Morsink, (unknown), Goda Choi, Marco R. de Groot, (unknown), Mar Bellido, (unknown), Laura Bungener, Kees Meijer, André B. Mulder, Gerwin Huls	4
2	Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation 2021 ·Bone Marrow Transplantation ·(unknown), (unknown), Walter J. F. M. van der Velden, Joop H. Jansen, Brigitte Bär, Nicolaas Schaap, (unknown), André B. Mulder, Marco R. de Groot, Frédéric Baron, Edo Vellenga, (unknown), Gerwin Huls	7
3	CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones 2021 ·Blood Advances ·(unknown), (unknown), Kees Meijer, Linde M. Morsink, (unknown), Carolien M. Woolthuis, Emanuele Ammatuna, (unknown), Bauke de Boer, Gerwin Huls, André B. Mulder, Jan Jacob Schuringa	7
4	The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis 2020 ·Haematologica ·Bauke de Boer, (unknown), Katja Apelt, Edo Vellenga, André B. Mulder, Gerwin Huls, Jan Jacob Schuringa	23
5	Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients 2019 ·Leukemia Research ·(unknown), (unknown), Eva van den Berg, André B. Mulder, Jan Jacob Schuringa, (unknown), Marco de Groot, Goda Choi, Geertruida H. de Bock, Edo Vellenga, Emanuele Ammatuna, Gerwin Huls	14
6	VEGFC Antibody Therapy Drives Differentiation of AML 2018 ·Cancer Research ·Kim R. Kampen, Frank J.G. Scherpen, Hasan Mahmud, Arja ter Elst, André B. Mulder, Victor Guryev, (unknown), Kim De Keersmaecker, Linda Smit, Steven M. Kornblau, Eveline S.J.M. de Bont	11
7	High protein S activity due to C4b‐binding protein deficiency in a 34‐year‐old Surinamese female with ischemic retinopathy 2018 ·Clinical Case Reports ·René Mulder, (unknown), (unknown), André B. Mulder, Michaël V. Lukens	5
8	Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia 2017 ·Cell Death and Disease ·Hendrik Folkerts, (unknown), Albertus T.J. Wierenga, Jennifer Jaques, André B. Mulder, Paul J. Coffer, Jan Jacob Schuringa, Edo Vellenga	73
9	B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains 2016 ·American Journal Of Pathology ·Linda M. Slot, Robbert Hoogeboom, Laura A. Smit, Thera A.M. Wormhoudt, Bart J. Biemond, Monique E.C.M. Oud, Esther J.M. Schilder-Tol, André B. Mulder, Aldo Jongejan, Antoine H. C. van Kampen, Philip M. Kluin, Jeroen E. J. Guikema, Richard J. Bende, Carel J.M. van Noesel	13
10	Quiz Page May 2014 2014 ·American Journal of Kidney Diseases ·(unknown), Femke Waanders, André B. Mulder, Wouter F.W. Bierman, F. Nanne Croles	3
11	Hypercoagulability and hypofibrinolysis in patients with human immunodeficiency virus infection partially resolve after antiretroviral treatment 2013 ·Journal of Thrombosis and Haemostasis ·Herman G. Sprenger, (unknown), André B. Mulder, Tjip S. van der Werf, Wouter F.W. Bierman, Karina Meijer, (unknown)	1
12	Chemotherapy-induced hypercoagulability and biomarkers for prediction of thromboembolic events in patients with metastatic testicular cancer 2013 ·Journal of Thrombosis and Haemostasis ·(unknown), Hink Boer, Renske Altena, Coby Meijer, J. D. Lefrandt, Janine Nuver, André B. Mulder, Ton Lisman, Pieter W. Kamphuisen, Jourik A. Gietema	0
13	Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients 2013 ·Journal of Hematology & Oncology ·(unknown), Ellen R. M. Scheepers, Nic J.G.M. Veeger, (unknown), André B. Mulder, Eva van den Berg, Edo Vellenga, Gerwin Huls	42
14	Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions 2012 ·Allergy ·J. J. van Doormaal, E. van der Veer, Pieter C. van Voorst Vader, P.M. Kluin, André B. Mulder, S. van der Heide, Suzanne Arends, Hanneke C. Kluin‐Nelemans, J. N. G. Oude Elberink, Jan G.R. de Monchy	42
15	The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria 2011 ·Journal of Thrombosis and Haemostasis ·Bakhtawar K. Mahmoodi, André B. Mulder, Femke Waanders, Henri M.H. Spronk, René Mulder, Maartje C.J. Slagman, Liffert Vogt, Gerjan Navis, Hugo Ten Cate, Hanneke C. Kluin‐Nelemans, Gozewijn D. Laverman	11
16	Low-dose rituximab is effective in pemphigus 2011 ·British Journal of Dermatology ·Barbara Horváth, Jan D. Huizinga, Hendri H. Pas, André B. Mulder, Marcel F. Jonkman	78
17	Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis 2010 ·Allergy ·Marek Niedoszytko, J. N. G. Oude Elberink, Marcel Bruinenberg, Bogusław Nedoszytko, Jan G.R. de Monchy, Gerard J. te Meerman, Rinse K. Weersma, André B. Mulder, Ewa Jassem, J. J. van Doormaal	17
18	Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases 2010 ·Annals of Hematology ·Lina Han, Jan Jacob Schuringa, André B. Mulder, Edo Vellenga	15
19	A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin 2010 ·Journal of Thrombosis and Haemostasis ·Bakhtawar K. Mahmoodi, Jolijn Brouwer, Min Ki ten Kate, Willem M. Lijfering, Nic J.G.M. Veeger, André B. Mulder, Hanneke C. Kluin‐Nelemans, J. van der Meer	85
20	Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation 1992 ·Annals of Hematology ·André B. Mulder, J. Th. M. de Wolf, Johannes W. A. Smit, J W van Oostveen, Edo Vellenga	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact